[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @ThomasFiligrane Thomas Philippart Thomas Philippart posts on X about $huma, $fms, investment, q2 the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1042346198353403905/interactions)  - X Week XXXXX -XX% - X Month XXXXX +80% - X Months XXXXXX +308% - X Year XXXXXX +7,409% ### Mentions: X [#](/creator/twitter::1042346198353403905/posts_active)  - X Week X no change - X Month X +33% - X Months XX +94% - X Year XX +1,800% ### Followers: XXX [#](/creator/twitter::1042346198353403905/followers)  - X Week XXX +1.60% - X Month XXX -XXXX% - X Months XXX +62% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1042346198353403905/influencer_rank)  ### Social Influence [#](/creator/twitter::1042346198353403905/influence) --- **Social category influence** [cryptocurrencies](/list/cryptocurrencies) [finance](/list/finance) **Social topic influence** [$huma](/topic/$huma), [$fms](/topic/$fms), [investment](/topic/investment), [q2](/topic/q2), [$60m](/topic/$60m), [stocks](/topic/stocks), [wall street](/topic/wall-street) **Top assets mentioned** [Huma Finance (HUMA)](/topic/$huma) [Fresenius Medical Care AG & Co. KGaA (FMS)](/topic/$fms) ### Top Social Posts [#](/creator/twitter::1042346198353403905/posts) --- Top posts by engagements in the last XX hours "🚨 WHEN A GLOBAL LEADER HIGHLIGHTS $HUMA IN ITS REPORT Fresenius Medical Care ($FMS) the worlds dialysis giant mentioned Humacyte in its Q2 2025 earnings presentation. 👉 The positive impact of the Humacyte remeasurement is clearly highlighted in their investor slides. 💡 Translation: - They hold $HUMA and are keeping their position. - They are publicly valuing this partnership/investment. - This isnt just an accounting line its a signal of confidence in the companys potential. 📊 When a global leader talks about you in their earnings its never by accident. $FMS $HUMA" [X Link](https://x.com/ThomasFiligrane/status/1954625591770075192) [@ThomasFiligrane](/creator/x/ThomasFiligrane) 2025-08-10T19:27Z XXX followers, 2554 engagements "🚨BTIG maintains $HUMA at BUY trimming target to $X (from $7). Thats still a +255 % upside from todays $XXXX level. 📈🫣 BTIG Analyst Ryan Zimmerman remains bullish on Humacytes bioengineered vessel (ATEV) platform a first-in-class regenerative medicine tech despite dilution from the recent $60M raise. #HUMA #biotech #investing #stocks #regenerativemedicine" [X Link](https://x.com/ThomasFiligrane/status/1977770813097992378) [@ThomasFiligrane](/creator/x/ThomasFiligrane) 2025-10-13T16:18Z XXX followers, 2176 engagements "🚨 HUMACYTE: WHEN OVERVALUED ACTUALLY MEANS FULL OF POTENTIAL Recently Simply Wall Street published a note suggesting that Humacyte (HUMA) is overvalued citing a price-to-book (P/B) ratio of 69.4x far above the biotech industry average of around 2.6x. At first glance that reasoning sounds logical: the higher the ratio the more expensive the company appears relative to its tangible assets. But in Humacytes case that argument doesnt really make sense. 🧬 A biotech not a bank Humacyte isnt an industrial or financial company with factories and buildings on its balance sheet. Its a pre-commercial" [X Link](https://x.com/ThomasFiligrane/status/1979892359925276966) [@ThomasFiligrane](/creator/x/ThomasFiligrane) 2025-10-19T12:48Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ThomasFiligrane Thomas Philippart
Thomas Philippart posts on X about $huma, $fms, investment, q2 the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXX +80%
- X Months XXXXXX +308%
- X Year XXXXXX +7,409%
Mentions: X #
- X Week X no change
- X Month X +33%
- X Months XX +94%
- X Year XX +1,800%
Followers: XXX #
- X Week XXX +1.60%
- X Month XXX -XXXX%
- X Months XXX +62%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence cryptocurrencies finance
Social topic influence $huma, $fms, investment, q2, $60m, stocks, wall street
Top assets mentioned Huma Finance (HUMA) Fresenius Medical Care AG & Co. KGaA (FMS)
Top Social Posts #
Top posts by engagements in the last XX hours
"🚨 WHEN A GLOBAL LEADER HIGHLIGHTS $HUMA IN ITS REPORT Fresenius Medical Care ($FMS) the worlds dialysis giant mentioned Humacyte in its Q2 2025 earnings presentation. 👉 The positive impact of the Humacyte remeasurement is clearly highlighted in their investor slides. 💡 Translation: - They hold $HUMA and are keeping their position. - They are publicly valuing this partnership/investment. - This isnt just an accounting line its a signal of confidence in the companys potential. 📊 When a global leader talks about you in their earnings its never by accident. $FMS $HUMA"
X Link @ThomasFiligrane 2025-08-10T19:27Z XXX followers, 2554 engagements
"🚨BTIG maintains $HUMA at BUY trimming target to $X (from $7). Thats still a +255 % upside from todays $XXXX level. 📈🫣 BTIG Analyst Ryan Zimmerman remains bullish on Humacytes bioengineered vessel (ATEV) platform a first-in-class regenerative medicine tech despite dilution from the recent $60M raise. #HUMA #biotech #investing #stocks #regenerativemedicine"
X Link @ThomasFiligrane 2025-10-13T16:18Z XXX followers, 2176 engagements
"🚨 HUMACYTE: WHEN OVERVALUED ACTUALLY MEANS FULL OF POTENTIAL Recently Simply Wall Street published a note suggesting that Humacyte (HUMA) is overvalued citing a price-to-book (P/B) ratio of 69.4x far above the biotech industry average of around 2.6x. At first glance that reasoning sounds logical: the higher the ratio the more expensive the company appears relative to its tangible assets. But in Humacytes case that argument doesnt really make sense. 🧬 A biotech not a bank Humacyte isnt an industrial or financial company with factories and buildings on its balance sheet. Its a pre-commercial"
X Link @ThomasFiligrane 2025-10-19T12:48Z XXX followers, XXX engagements